Researchers at Texas Children's Hospital have uncovered a novel biological pathway that can lead to seizures when disrupted. This finding provides a new approach for improving genetic diagnosis and treatment for epilepsy cases with unknown origins. The study also reveals that specific combinations of defective genes can cause seizures,...
Researchers found subtle patterns in brain activity while children listened to speech linked to verbal communication abilities in autistic youths. Altered brain signals suggested the brain may process speech less efficiently, with noisier signals associated with lower scores on everyday verbal communication.
Researchers analyzed genetic data from almost 100,000 people across eleven world regions, identifying regional differences in gene variants GBA1 and LRRK2. This study is crucial for globally equitable diagnostics and therapies as it highlights the need to consider ancestry when diagnosing Parkinson's disease.
Researchers analyzed data from over 500,000 births in Scotland to examine the effects of epidural analgesia on newborn health. The study found no association between epidural use and serious neurological conditions, sepsis, or cerebral palsy in childhood.
Researchers have developed a new drug candidate, SB-0110, that boosts L-dopa's benefits while reducing dyskinetic side effects in animal models of Parkinson’s disease. The compound preserves the gene-activity patterns tied to L-dopa’s benefits while counteracting biological changes associated with dyskinesia.
Researchers at Texas A&M University have found a way to intervene early in traumatic brain injuries using a natural, gut-derived chemical that prevents post-traumatic epilepsy from taking root. The treatment reduced brain inflammation, improved memory and mood, protected brain cells, made seizures both rarer and harder to trigger.
Researchers discovered that reducing microglial activity worsened abnormal electrical activity and increased seizure-like events in a mouse model of Alzheimer's disease. Microglia are not just drivers of inflammation but also perform important housekeeping functions to maintain healthy brain activity.
Scientists have unveiled a new structure of the kinesin-1 protein, showing how cells control its on-off switch. The discovery could shed light on incurable neurodegenerative diseases such as ALS and Charcot-Marie-Tooth Disease Type 2.
A scoping review suggests astrocytic dysfunction may precede neuronal degeneration in CTE. Astrocytes' dysregulation contributes to the development of CTE's characteristic features through mechanisms including astrogliosis, disrupted waste clearance pathways, and chronic neuroinflammation.
A review of hundreds of studies suggests that polyphenol-rich foods like berries, tea, and olive oil may support healthy brain aging by reducing inflammation and promoting nerve cell function. While no single food can prevent Alzheimer's disease, a balanced diet rich in plant-based foods may help preserve cognitive function over time.
A team of surgeons used robot-assisted stereotactic surgery to treat a patient with multiple deep brain abscesses, achieving complete resolution and rapid neurological recovery. The minimally invasive strategy reduced surgical trauma and accelerated healing.
A new study published in Ophthalmology Science has confirmed that The CVI Range Assessment is a valid and reliable instrument for evaluating functional vision in children with Cortical Visual Impairment (CVI). This finding provides evidence that the widely used assessment meets rigorous clinical and psychometric standards, offering a s...
A new study published in the Journal of Alzheimer's Disease estimates that dementia-related costs across 30 high-income European countries total €221 billion annually. Family caregivers carry a significant portion of this burden, providing an estimated €128 billion in unpaid care.
A recent Phase II open-label study evaluated vamorolone in 20 steroid-naive boys aged 2-4 years with DMD, showing dose-dependent improvements in motor function. The traditional corticosteroids often cause growth stunting and other complications in long-term use.
Researchers discovered that damaged myelin generates abnormal rhythms in the sleeping brain, linked to disruptions in brain circuit stability. This finding may help design non-invasive approaches to repair myelin during sleep, improving sleep quality in patients with MS and Alzheimer's disease.
A novel gene promoter called cmGAD67 shows promise for treating drug-resistant epilepsy by selectively stimulating inhibitory neurons. The study found that the promoter drove strong and highly selective gene expression in specific brain regions, reducing abnormal electrical activity and seizures.
A new $250,000 grant will support the development of a novel therapeutic approach for sepsis-associated neurocognitive dysfunction. The treatment aims to protect the brain from inflammation-related damage during and after sepsis, potentially preventing or slowing neurodegeneration and cognitive decline.
Researchers present new insights into an iPSC-derived neural progenitor cell therapy for chronic ischemic stroke, demonstrating safety and biological activity over extended follow-up. The findings have the potential to expand treatment options for patients living with chronic stroke disability.
Two ECNP-affiliated journals, European Neuropsychopharmacology and Neuroscience Applied, have seen significant increases in citation rates. The rise reflects growing interest in the biological underpinnings of mental health, as reflected in the journal's focus on precision psychiatry.
Research suggests alcohol interacts with Alzheimer's-related brain circuits in distinct ways, depending on the type of pathological change. Alcohol reduced communication in amyloid-beta models but increased it in tau models, highlighting an important principle in biology.
A University at Buffalo-led team has developed a method to reliably measure cortical lesions in MS using artificial intelligence. By analyzing existing MRI scans, they found over 11,000 cortical lesions, revealing new insights into the disease's progression and cognitive impairment.
Researchers at King's College London discovered a molecule linked to chronic inflammation disrupts brain neuron formation, highlighting a pathway with therapeutic potential for conditions like Alzheimer's disease and depression. High cytokine levels trigger an 'immune alert' state, reducing new nerve cell production.
A new study reveals IL-6 plays a crucial role in regulating neuroinflammation and protecting the nigrostriatal pathway in Parkinson's disease. The research found that restoring IL-6 levels can reverse aggravated pathology and partially ameliorate motor dysfunction in mice.
Researchers identified disrupted neural circuits behind Huntington's disease and used optogenetics to selectively activate key neurons, restoring function and improving motor skills. The study provides hope for future therapies targeting specific brain circuit imbalances.
The study reveals how genetic mutations disrupt muscle signaling in CMS, a family of genetic disorders that weaken communication between nerves and muscles. Researchers identified promising new therapeutic opportunities, including a potential use for an existing antidepressant.
A study published in Frontiers in Psychology found that the time it takes for a therapist and patient to reach peak heart-rate synchrony during a music therapy session is around 25 minutes. This suggests that therapy sessions may need to allow sufficient time for this synchronization to develop.
A new study finds that multiple sclerosis has a substantial impact on social life and work, with 51% of people reporting an effect. The study highlights the need for comprehensive care addressing not only physical health but also daily functioning, employment, and overall wellbeing.
Research presented at the European Academy of Neurology Congress 2026 found that women with Parkinson's disease had significantly greater amyloid plaque burden and neuritic plaque density compared to men. The study suggests that women may be more susceptible to Alzheimer's-related changes in the brain.
A simple bedside eye test may predict recovery of consciousness in patients with severe brain injuries, according to new research. The late light-off response (LOR) phase of the pupil response predicted improvements in consciousness seven days later.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
Salk Institute researchers discovered chronoferroptosis, a chronic stress pathway in cells that causes neurons to become less resilient over time and more susceptible to neurodegeneration. Iron accumulation was found to lower the cells' defenses, making them more vulnerable to stressors.
Researchers study blind Mexican cavefish to understand how evolution rewires the brain and shapes behavior. They found that cavefish become more active in light, a response believed to help them avoid predators.
A new commission, launched at the Texas Brain Economy Summit, aims to define, measure, and operationalize brain capital, a concept encompassing both brain health and critical cognitive skills. The initiative seeks to address the gap in economic planning and promote brain health as a driver of economic resilience.
Researchers developed zebrafish model that reproduces key features of CADASIL, a hereditary disease causing brain damage and recurrent strokes. The study found progressive decline in cerebral blood flow and impaired learning ability, similar to human patients.
Researchers discovered blood RNA biomarkers that could support earlier diagnosis of Alzheimer's disease, potentially reducing the need for invasive tests. They identified brain-specific markers in circulating blood nanoparticles, which may offer a minimally invasive approach for diagnosing the progressive neurodegenerative disease.
The American Heart Association and International Federation for Emergency Medicine collaborate to strengthen training, research, and systems of care for emergency cardiovascular and resuscitative care. The three-year agreement aims to improve access to training, education, and emergency care resources in low- and middle-income countries.
A new research project will study the effect of immune cell aging on Parkinson's disease risk and progression. The team aims to identify individuals at greater risk for Parkinson's disease and develop targeted treatments.
A novel rehabilitation system connects therapists and patients through robotic exoskeletons, enabling real-time adaptation and personalized care. Stroke survivors who used the system demonstrated improved joint range of motion, longer and higher steps, and high levels of motivation.
The University of Michigan has successfully implanted the first-in-human Paradromics wireless brain-computer interface, designed to restore communication for patients with difficulty speaking. The clinical trial will focus on the device's long-term safety and assess its ability to restore communication through synthesized text and speech.
Researchers at University of Michigan Health have implanted the first wireless brain-computer interface (BCI) to restore communication in a patient with motor neuron disease. The study, called Connect-One Early Feasibility Study, aims to assess the device's long-term safety and effectiveness in synthesizing text and speech.
Researchers have identified an experimental molecule called OLE that can restore part of the brain's protective function against Alzheimer's disease. The compound helps microglia enclose and contain beta-amyloid plaques, reducing their size and toxicity.
A new study revealed that retinal photographs can accurately predict many common risk factors associated with developing Alzheimer's disease. The AI model identified regions of the retina linked to Alzheimer's risk factors, such as arteries and optical nerve, and predicted lifestyle factors like smoking and alcohol use.
A brain-computer interface (BCI) system has been developed at the University of California - Davis Health, allowing a person with severe paralysis caused by amyotrophic lateral sclerosis (ALS) to communicate, work, and interact with the digital world without assistance. The BCI system has been tested in a 47-year-old man with ALS, who ...
Research finds different underlying factors driving growth in people living with Parkinson's disease, multiple sclerosis, and motor neuron disease. Improvements in treatment and care contribute to increased life expectancy for MS and MND patients.
A USC study found subtle but widespread differences in the brain's communication networks in people with bipolar disorder, relating these differences to illness severity and treatment. The research team analyzed brain scans from 449 individuals with bipolar disorder and 510 healthy controls, revealing less densely connected networks an...
A new EPI-SLEEP study will investigate the impact of personalized in-ear sleep technology on sleep disturbances and circadian health in adults with epilepsy. The study aims to generate robust evidence for a low-risk approach to improving sleep without adding medication burden.
A study analyzing French and Swedish national health databases reveals a rise in Parkinson's disease, multiple sclerosis, and motor neuron diseases' prevalence worldwide. Improved life expectancy and therapies contribute to the increase in multiple sclerosis cases, while population aging is the primary driver of ALS rising incidence.
A new compound, compound 10, has shown promising effects in slowing the development of Alzheimer's disease by inhibiting GRK2 aggregation. This leads to improved mitochondrial function and reduced amyloid beta deposition, potentially breaking a vicious circle that contributes to dementia progression.
A pioneering pilot clinical trial showed that spinal cord stimulation improved arm strength by 32% in stroke survivors, with significant reductions in muscle spasticity. The intervention required minimal training time and was safe with no serious adverse events.
University of Delaware researchers are developing an AI-powered approach to diagnose epilepsy earlier by identifying subtle EEG patterns. The method, tested on mice with genetic forms of epilepsy, shows promise for detecting biomarkers that flag underlying changes in brain activity before seizures occur.
The new vaccine adjuvant induces a strong mucosal immune response in the GI tract, which is crucial for eradicating polio. The researchers achieved a 20-fold increase in antibodies needed for mucosal immunity compared to the existing injectable polio vaccine.
Researchers have identified an experimental molecule called OLE that helps restore microglia's protective function against Alzheimer's disease. The compound reduces beta-amyloid plaque size and toxicity, improving cognitive performance in memory tests.
Researchers developed a new reference model for the human brain using diffusion MRI scans from over 54,000 people. The model provides growth charts for white matter neural pathways, helping identify subtle changes linked to aging, Alzheimer's, schizophrenia risk and other neurological conditions.
A groundbreaking study created a world's first pure cerebral microbleed model by targeting brain vascular collagen IV using CRISPR/Cas9 gene editing. The research implicated dysfunctional collagen in tiny brain hemorrhages, which are strongly associated with dementia and cognitive decline.
A major clinical trial found ocrelizumab significantly slows disability progression and preserves hand and upper-limb function in people with primary progressive multiple sclerosis. The study included over 1,000 patients across 22 countries and showed a 30% lower risk of disability progression.
A new brain imaging test can detect Alzheimer's disease pathology in twice as many people before symptoms appear. The test uses a new tau PET tracer that identifies more tau-positive cases than the current standard, leading to better decisions about who is on an Alzheimer's trajectory.
A new approach combines MRI scans and AI tools to measure fluid flow in the brain, shedding light on the glymphatic system’s mechanics. The study reveals two main ways the system washes away particles, with one way moving faster than the other.
Guldner will investigate cellular communication mechanisms that regulate brain aging and disease, targeting those interactions to preserve brain health. His research aims to build the scientific foundation for future strategies to protect cognitive health by revealing early cellular shifts that precede disease.
Researchers identified a potential new way to relieve chronic pain linked to neurofibromatosis type 1 (NF1). Blocking MAPK signaling with a MEK inhibitor lowered GDNF levels in Schwann cells and reduced pain-like responses in mice.
Research analyzed over 35.8 million emergency department visits to compare fall-related injury risks among adults with and without intellectual and/or developmental disabilities or cerebral palsy. Adults with these conditions were more likely to visit the emergency department due to falls, especially at younger ages.